Market Research

Horseradish Peroxidase Market (Substrate: ABTS, OPD, TMB, and Others; and Application: Immunoassays and Biosensors) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 217 Pages Transparency Market Research Pvt. Ltd. February, 2024 TNPR18668738
Best Price Guarantee
Price from $5,795
Length 217 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date February, 2024
SKU TNPR18668738

Horseradish Peroxidase Market (Substrate: ABTS, OPD, TMB, and Others; and Application: Immunoassays and Biosensors) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Horseradish Peroxidase Market – Scope of Report

TMR’s report on the global horseradish peroxidase market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global horseradish peroxidase market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global horseradish peroxidase market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the horseradish peroxidase market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global horseradish peroxidase market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global horseradish peroxidase market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global horseradish peroxidase market.

The report delves into the competitive landscape of the global horseradish peroxidase market. Key players operating in the global horseradish peroxidase market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global horseradish peroxidase market profiled in this report.

Key Questions Answered in Global horseradish peroxidase Market Report
  • What is the sales/revenue generated by horseradish peroxidase across all regions during the forecast period?
  • What are the opportunities in the global horseradish peroxidase market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Horseradish Peroxidase Market – Research Objectives and Research Approach

The comprehensive report on the global horseradish peroxidase market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global horseradish peroxidase market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global horseradish peroxidase market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Horseradish Peroxidase Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Horseradish Peroxidase Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Horseradish Peroxidase Market Analysis and Forecast, by Substrate
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Substrate, 2017–2031
6.3.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
6.3.2. OPD (ophenylenediamine dihydrochloride)
6.3.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
6.3.4. Others
6.4. Market Attractiveness, by Substrate
7. Global Horseradish Peroxidase Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Immunoassays
7.3.1.1. ELISA
7.3.1.2. Blot Test
7.3.1.3. Others
7.3.2. Biosensors
7.3.3. 7.4 Market Attractiveness, by Application
8. Global Horseradish Peroxidase Market Analysis and Forecast, by Grade
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Grade, 2017–2031
8.3.1. Grade I
8.3.2. Grade II
8.3.3. Grade III
8.4. Market Attractiveness, by Grade
9. Global Horseradish Peroxidase Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Biopharmaceutical Companies
9.3.2. Academic & Research Centers
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Horseradish Peroxidase Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Horseradish Peroxidase Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Substrate, 2017–2031
11.2.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
11.2.2. OPD (ophenylenediamine dihydrochloride)
11.2.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
11.2.4. Others
11.3. Market Attractiveness, by Substrate
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Immunoassays
11.4.1.1. ELISA
11.4.1.2. Blot Test
11.4.1.3. Others
11.4.2. Biosensors
11.5. Market Attractiveness, by Application
11.6. Market Value Forecast, by Grade, 2017–2031
11.6.1. Grade I
11.6.2. Grade II
11.6.3. Grade III
11.7. Market Attractiveness, by Grade
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Biopharmaceutical Companies
11.8.2. Academic & Research Centers
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Substrate
11.11.2. By Application
11.11.3. By Grade
11.11.4. By End-user
11.11.5. By Country
12. Europe Horseradish Peroxidase Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Substrate, 2017–2031
12.2.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
12.2.2. OPD (ophenylenediamine dihydrochloride)
12.2.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
12.2.4. Others
12.3. Market Attractiveness, by Substrate
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Immunoassays
12.4.1.1. ELISA
12.4.1.2. Blot Test
12.4.1.3. Others
12.4.2. Biosensors
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by Grade, 2017–2031
12.6.1. Grade I
12.6.2. Grade II
12.6.3. Grade III
12.7. Market Attractiveness, by Grade
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Biopharmaceutical Companies
12.8.2. Academic & Research Centers
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Substrate
12.11.2. By Application
12.11.3. By Grade
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Horseradish Peroxidase Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Substrate, 2017–2031
13.2.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
13.2.2. OPD (ophenylenediamine dihydrochloride)
13.2.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
13.2.4. Others
13.3. Market Attractiveness, by Substrate
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Immunoassays
13.4.1.1. ELISA
13.4.1.2. Blot Test
13.4.1.3. Others
13.4.2. Biosensors
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by Grade, 2017–2031
13.6.1. Grade I
13.6.2. Grade II
13.6.3. Grade III
13.7. Market Attractiveness, by Grade
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Biopharmaceutical Companies
13.8.2. Academic & Research Centers
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Substrate
13.11.2. By Application
13.11.3. By Grade
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Horseradish Peroxidase Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Substrate, 2017–2031
14.2.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
14.2.2. OPD (ophenylenediamine dihydrochloride)
14.2.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
14.2.4. Others
14.3. Market Attractiveness, by Substrate
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Immunoassays
14.4.1.1. ELISA
14.4.1.2. Blot Test
14.4.1.3. Others
14.4.2. Biosensors
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by Grade, 2017–2031
14.6.1. Grade I
14.6.2. Grade II
14.6.3. Grade III
14.7. Market Attractiveness, by Grade
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Biopharmaceutical Companies
14.8.2. Academic & Research Centers
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Substrate
14.11.2. By Application
14.11.3. By Grade
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Horseradish Peroxidase Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Substrate, 2017–2031
15.2.1. ABTS (2,2’- Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
15.2.2. OPD (ophenylenediamine dihydrochloride)
15.2.3. TMB (3,3’, 5,5’-tetramethylbenzidine)
15.2.4. Others
15.3. Market Attractiveness, by Substrate
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Immunoassays
15.4.1.1. ELISA
15.4.1.2. Blot Test
15.4.1.3. Others
15.4.2. Biosensors
15.5. Market Attractiveness, by Application
15.6. Market Value Forecast, by Grade, 2017–2031
15.6.1. Grade I
15.6.2. Grade II
15.6.3. Grade III
15.7. Market Attractiveness, by Grade
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Biopharmaceutical Companies
15.8.2. Academic & Research Centers
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Substrate
15.11.2. By Application
15.11.3. By Grade
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Abcam Limited
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bio-Rad Laboratories, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck KGaA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. BBI Solutions
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Takara Bio Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Promega Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. F. Hoffmann-La Roche Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. TOYOBO Co., Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Oriental Yeast Co., Ltd.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. GenScript
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings